THORACIC MEDICINE
OFFICIAL PEER-REVIEWED
HIGHLIGHTS FROM
IN THIS ISSUE
Distributed as a professional
courtesy by
Prevention and Early
Treatment of Acute Lung Injury
The absence of Phase 3 trials showing a mortality benefit from pharmacological
treatment of acute lung injury has led to a shift toward identifying patients
who are at risk for lung injury and employing risk modification and treatment
to prevent progression to respiratory failure or the need for mechanical
ventilation. See page 6.
ALSO
Management of
Acute Pulmonary
Embolism
Clinical Trial Highlights:
The Science Behind
Thoracic Medicine
Challenges in
Lung Cancer
Screening
Table of Contents for the Digital Edition of MD Conference Express ATS 2013